Citizens Financial Group Inc Insulet Corp Transaction History

Citizens Financial Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	SELL	$260.36 - $307.27 $299,674 - $353,667	-1,151 Closed	0 $0
Q2 2021 Aug 04, 2021	BUY	$225.52 - $304.06 $259,573 - $349,973	1,151 New	1,151 $316,000
Q3 2020 Nov 12, 2020	SELL	$192.55 - $236.59 $207,183 - $254,570	-1,076 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$159.17 - $224.73 $14,484 - $20,450	91 Added 9.24%	1,076 $209,000
Q1 2020 May 08, 2020	BUY	$130.01 - $216.44 $124,939 - $207,998	961 Added 4004.17%	985 $163,000
Q4 2019 Feb 07, 2020	BUY	$144.81 - $186.0 $3,475 - $4,464	24 New	24 $4,000

659

63.5M

385K

773K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $16.1B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Citizens Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Citizens Financial Group Inc with notifications on news.